India's Zydus Life posts Q2 profit rise on steady US demand November 12, 2024 Indian generic drugmaker Lupin reported a bigger-than-expected rise in second-quarter profit on Thursday, driven by ...

New Delhi, Jan 26 Chairman of Zydus Lifesciences, Pankaj Patel ... out as an entrepreneur to contribute to nation-building and making India self-reliant in life sciences. This commitment to science, ...

Ahmedabad (Gujarat) [India], January 26 (ANI): Chairman of Zydus Lifesciences, Pankaj Patel ... to contribute to nation-building and make India self-reliant in life sciences. “This commitment to ...

Zydus said Desidustat, sold under the Oxemia trademark, is a prescription drug approved in India for patients with CKD induced anemia, and can be taken only under the advice and guidance of a ...

The USFDA has allowed Zydus to manufacture and market Estradiol Transdermal System USP in the U.S; the drug will be produced at the group’s facility in Moraiya, Ahmedabad. India's healthcare firms ...